{"schema_version":"secwatch.filing_event.v1","accession":"0001847903-22-000042","form_type":"8-K","ticker":"CNTA","cik":"0001847903","company_name":"Centessa Pharmaceuticals plc","filed_at":"2022-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.422503+00:00","generated_at":"2026-06-24T18:41:13.460701+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Centessa CAO resigns; CFO to add principal accounting officer role; RSU retention grants approved","bullets":["Marella Thorell resigns as Chief Accounting Officer effective July 31, 2022, to pursue another opportunity; no disagreement with the company.","CFO Gregory Weinhoff will assume principal accounting officer duties effective July 31, in addition to his CFO role.","Board approved RSU retention grants: CEO Saurabh Saha 750,000 shares, CFO Weinhoff 230,000, EVP Yver 100,000; vest quarterly over 10 quarters starting Sept 30, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001847903-22-000042","json":"https://secwatch.observer/filing/0001847903-22-000042.json","markdown":"https://secwatch.observer/filing/0001847903-22-000042.md","text":"https://secwatch.observer/filing/0001847903-22-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847903/000184790322000042/0001847903-22-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847903/000184790322000042/cnta-20220701.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T18:41:13.460701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"50b9b6d69a","claim":"Gregory Weinhoff changed role as Chief Financial Officer at Centessa Pharmaceuticals plc.","evidence_excerpt":"Effective as of July 31, 2022, Gregory Weinhoff, M.D., M.B.A., the Company’s Chief Financial Officer, will assume the duties and responsibilities of the Company’s principal accounting officer, in addition to the Company’s principal financial officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000184790322000042/0001847903-22-000042-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"assumed duties of principal accounting officer"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"ff595e0c51","claim":"Marella Thorell resigned as Chief Accounting Officer at Centessa Pharmaceuticals plc.","evidence_excerpt":"On July 1, 2022, Marella Thorell notified Centessa Pharmaceuticals plc (the “Company”) of her decision to resign her position as the Company’s Chief Accounting Officer, and its principal accounting officer, effective as of July 31, 2022 to pursue another professional opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847903/000184790322000042/0001847903-22-000042-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}